This is the FDA’s first guidance focusing on psychedelic drug development. Phillips Lytle law firm takes a closer look. The post FDA Draft Guidance on...
A statewide proposal, if passed, will allocate settlement funds from lawsuits against corporations involved in the opioid crisis towards research into...
With clinical trials moving MDMA toward FDA approval, celebrities continuing to share their psychedelic experiences, and politicians supporting new research...
Legal psychedelic treatment doesn’t mean much if no one can afford it. The cost of psychedelic-assisted therapy is undoubtedly high, and ensuring equitable...
Local initiatives and cultural changes are playing a pivotal role in spearheading decriminalization and legalization efforts and the future of legal psychedelics. The...
Public comment on the draft proposal will be collected for the next 60 days. The post FDA Issues Draft Guidance on Clinical Trials for Psychedelic Drugs...
With clinical trials moving MDMA toward FDA approval, celebrities continuing to share their psychedelic experiences, and politicians supporting new research...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed The post News...
The FDA has published new guidance for researchers investigating the use of psychedelic drugs for the treatment of medical conditions. The post FDA Issues...
This story was republished with permission from Crain’s New York. A significant player in the psychedelics industry has received a $5 million infusion...